Skip to main content
. 2018 Aug 22;9:884. doi: 10.3389/fphar.2018.00884

Figure 7.

Figure 7

The discriminatory ability of SCMs between MM patients and healthy controls was analyzed using an ROC curve in Validation phase. (A), PC(16:0/16:0); (B), PC(18:3(6Z,9Z,12Z)/16:0); (C), 2-Hexenoylcarnitine; (D), 1-Methyladenosine. ROC, receiver operating characteristic curve. ROC curves and AUC were obtained by SPSS22.0 software. The HC, RG, and AG groups in Validation phase included 20, 26, 29 subjects, respectively.